Efficacy of the Erchonia Corporation THL™ for Providing Relief of Tinnitus Symptoms

NATerminatedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

May 10, 2022

Primary Completion Date

December 9, 2022

Study Completion Date

December 9, 2022

Conditions
Tinnitus
Interventions
DEVICE

Erchonia® THL™

The Erchonia® THL™ is made up of (2) 405-nanometer violet laser diodes mounted in a portable handheld device. The diodes are positioned approximately 4 inches from the skin and applied in a continuous back and forth sweeping motion from the top of the ear down the side of the neck. The treatments will be self-administered by the subject at his or her's place of residence, once per day for 28 days. Each procedure administration lasts 5 minutes per ear, for a total of 10 minutes.

DEVICE

Placebo Laser

The Placebo Laser has the same appearance as the Erchonia® THL™ but does not emit any therapeutic light. The diodes are positioned approximately 4 inches from the skin and applied in a continuous back and forth sweeping motion from the top of the ear down the side of the neck. The treatments will be self-administered by the subject at his or her's place of residence, once per day for 28 days. Each procedure administration lasts 5 minutes per ear, for a total of 10 minutes.

Trial Locations (1)

94520

Valley Audiology, Concord

Sponsors
All Listed Sponsors
lead

Erchonia Corporation

INDUSTRY